• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov3
Shrader's Focus on Healthcare Industry Stocks
17:02
Oct30
Inmune Bio released FY2025 9 Months earnings on October 30 After-Market EST, actual revenue USD 50K, actual EPS USD -1.7261
23:00
Inmune Bio released FY2025 Q3 earnings on October 30 After-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2434 (forecast USD -0.325)
23:00
Oct23
Inmune Bio to Release FY2025 Q3 Earnings on October 30 After-Market EST, Forecast EPS USD -0.325
00:05
Aug7
Inmune Bio released FY2025 Semi-Annual earnings on August 7 After-Market EST, with actual revenue of USD 50K and EPS of USD -1.4933
23:00
Inmune Bio released FY2025 Q2 earnings on August 7 After-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.0497 (forecast USD -0.3816)
23:00

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -6.472 M, EPS -0.2434

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -24.46 M, EPS -1.0497

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 50 K, Net Income -9.739 M, EPS -0.4329

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
25.440
+276.44%
+18.682
SMX
331.980
+135.45%
+190.980
WHLR
6.410
+97.84%
+3.170
DBRG
14.120
+45.27%
+4.400
TORO
5.800
+40.44%
+1.670
TDIC
0.3937
+40.21%
+0.113
LICN
4.070
+38.91%
+1.140
SPHL
4.530
+36.04%
+1.200
ALMS
11.120
+33.98%
+2.820
WAI
3.360
+32.28%
+0.820
View More